RESUMO
PVDC and three non-chlorinated polymers (PP, PET, and PA) were incinerated at 700-850 degrees C in a laboratory-scale quartz tubular furnace in the presence of HCl (ca. 500 ppm congruent with 0.8 mg/l), and the gas-phase formation of PCDD/Fs, their putative precursors and their homologue profiles were investigated. The addition of HCl had little or no apparent effect on the level of PCDD/Fs formation during PVDC combustion, and their homologue profiles were quite different from those of the three non-chlorinated polymers. With PVDC, O8CDD and particularly O8CDF were by far most prevalent, apparently as a result of the selective formation of the precursors. With each of the three non-chlorinated polymers, combustion at 800 degrees C or higher in the presence of HCl resulted in PCDD/Fs formation at levels equaling or exceeding those observed with PVDC. In trials made with one of them (PP) under the same conditions but using a large polymer sample (100 mg vs 20 mg in all other trials), the level of PCDD/Fs formation was far higher than with the smaller polymer samples, and thus demonstrated the importance of appropriate combustion conditions for polymer incineration.
Assuntos
Benzofuranos/análise , Dioxinas/análise , Ácido Clorídrico/química , Incineração , Cloreto de Polivinila/análogos & derivados , Cloreto de Polivinila/química , Dibenzofuranos Policlorados , Cromatografia Gasosa-Espectrometria de MassasRESUMO
Stabilizers (epoxidized linseed oil and epoxidized soybean oil) and plasticizers (acetyl tributyl citrate, diacetyl monolauryl glyceride and dibutyl sebacate) commonly used in polyvinylidene chloride (PVDC) films and extracts of such films were investigated for estrogenic and androgenic activity by means of estrogen receptor (ER) and androgen receptor (AR) competitive ligand-binding assays. Further, in in vivo experiments, ovariectomized Sprague-Dawley rats were observed for uterine wet weight change, uterine endometrium hyperplasia and vaginal mucosa cornification, following administration of each test compound or extract orally (0.5 or 500 mg/kg) or subcutaneously (0.5 or 100 mg/kg). No significant response or change was observed with any of the test compounds or extracts, either in vitro or in vivo. The results thus indicate that neither the stabilizers and plasticizers used in PVDC films, nor their extracts, exert sex-hormonal activity.